Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
A drug for alcoholism can also treat cancer by targeting macrophages
Developing a therapy to combat cancer remains one of the most difficult challenges in medical…
Brain tumours remodel neuronal synapses to promote growth
Scientists at Baylor College of Medicine, USA, have found new evidence that glioma, a lethal…
Never too late to quit: Protective cells could cut risk of lung cancer for ex-smokers
Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk…
Doctors: the patient I’ll never forget
By Sarah Smith – The Guardian. Four doctors and their extraordinary patients tell their stories Professor Nigel Heaton, 58, is…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.